Management in Medistim ASA purchases shares
Medistim ASA (MEDI) · publisert 16. november 2021 kl. 08:00 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Hæge Wetterhus | VP marketing | Kjøp | 663 | 301,7 NOK | 15. november 2023 | – | – |
| Anne Waaler | VP Medical | Kjøp | 1 989 | 301,7 NOK | 15. november 2023 | – | – |
| Roger Morberg | VP sales | Kjøp | 1 989 | 301,7 NOK | 15. november 2023 | – | – |
| Erik Swensen | VP development | Kjøp | 994 | 301,7 NOK | 15. november 2023 | – | – |
| Tone Veiteberg | VP QA\Reg | Kjøp | 1 989 | 301,7 NOK | 15. november 2023 | – | – |
| Medistim Norge AS | CEO | Kjøp | 1 326 | 301,7 NOK | 15. november 2023 | – | – |
| Håkon Grøthe | VP Innovation | Kjøp | 1 989 | 301,7 NOK | 15. november 2023 | – | – |
| Mike Farbelow | President in Medistim USA Inc | Kjøp | 1 989 | 301,7 NOK | 15. november 2023 | – | – |
| Thomas Jakobsen | CFO | Kjøp | 2 652 | 301,7 NOK | 15. november 2023 | – | – |
| Medistim ASA | – | Salg | 15 578 | 301,7 NOK | 15. november 2023 | – | – |
Meldingstekst
Management in Medistim ASA has the 15th of November purchased shares form Medistim ASA. This is part of the company long term incentive plan approved by the general meeting the 27th of April. Price per share was NOK 301,7. The following members of management has purchased shares:
VP marketing Hæge Wetterhus purchased 663 and has 663 shares after the purchase.
VP Medical Anne Waaler purchased 1989 shares and has 2.440 shares after the purchase.
VP sales Roger Morberg purchased 1989 shares and has 10427 shares after the purchase.
VP development Erik Swensen purchased 994 shares and has 10994 shares after the purchase.
VP QA\Reg Tone Veiteberg purchased 1989 shares and has 1989 shares after the purchase.
CEO in Medistim Norge AS purchased 1326 shares and has 1326 shares after the purchase.
VP Innovation Håkon Grøthe purchased 1989 shares and has 1989 shares after the purchase.
President in Medistim USA Inc, Mike Farbelow, purchased 1989 shares and has 1989 shares after the purchase.
CFO Thomas Jakobsen purchased 2652 shares and has 22748 shares after the purchase.
Medistim ASA has sold 15578 shares and has 108422 owns shares after the sale.